SNYNF:OTCMKTS
Sanofi SA
78,55 USD
0,00%
(0,00) 1D
15-окт., 12:34:26 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SNYNF...
Mkt. cap
98,00 млд
Avg. vol.
5,39 миң
Volume
117,00
52-wk high
106,34 USD
52-wk low
76,76 USD
Beta
0,32
Shares outstanding
1,21 млд
No. of employees
75 миң
Mkt. cap
98,00 млд
Avg. vol.
5,39 миң
Volume
117,00
52-wk high
106,34 USD
52-wk low
76,76 USD
Beta
0,32
Shares outstanding
1,21 млд
No. of employees
75 миң
News stories
From web sources and news partners
ad-hoc-news.de
·
2 саат мурун
Sanofi expands antibody alliance: what it means for Sanofi stock
Simply Wall Street
·
1 күн мурун
AI Drug Candidate Might Change The Case For Investing In Sanofi (ENXTPA:SAN)
Utah Business
·
1 күн мурун
Recursion prices $200M stock offering as Sanofi picks a partnered drug candidate
Yahoo Finance
·
1 күн мурун
Sanofi (ENXTPA:SAN) Stock Looks Reasonable After Its Antibody Deal
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOBelén Garijo | Paul Hudson
Employees74,8 миң
Founded1973
HeadquartersПариж, Иль-де-Франция, Франция
SectorPharmaceutical industry
Websitesanofi.com